AHRQ completes systematic reviews related to the treatment of chronic and acute pain

The Agency for Healthcare Research and Quality’s (AHRQ) Evidence-based Practice Centers (EPCs) recently released five systematic reviews related to the treatment of chronic and acute pain. The Centers for Disease Control and Prevention (CDC) funded AHRQ to conduct these reviews of the scientific evidence that has been published since the release of the CDC’s Guideline for Prescribing Opioids for Chronic Pain – United States, 2016. The five systemic reviews include Noninvasive Nonpharmacological Treatments for Chronic Pain, Nonopioid Pharmacologic Treatments for Chronic Pain, Opioid Treatments for Chronic Pain, Treatments for Acute Pain, and Acute Treatments for Episodic Migraines. The CDC will include results from these systematic reviews as they work to update their Guideline document.

1 view0 comments

Recent Posts

See All

FDA Approves Higher Dosage of Naloxone

The Food and Drug Administration recently announced the approval of a higher dose of naloxone nasal spray to treat opioid overdose. The FDA previously approved 2 mg and 4 mg naloxone products and has